|1 Table of Contents
|1.1 List of Tables
|1.2 List of Figures
2 Introduction
2.1 Cardiovascular Monitoring Devices Overview
3 Products under Development
3.1 Cardiovascular Monitoring Devices – Pipeline Products by Stage of Development
3.2 Cardiovascular Monitoring Devices – Pipeline Products by Segment
3.3 Cardiovascular Monitoring Devices – Pipeline Products by Territory
3.4 Cardiovascular Monitoring Devices – Pipeline Products by Regulatory Path
3.5 Cardiovascular Monitoring Devices – Pipeline Products by Estimated Approval Date
3.6 Cardiovascular Monitoring Devices – Ongoing Clinical Trials
4 Cardiovascular Monitoring Devices – Pipeline Products under Development by Companies
4.1 Cardiovascular Monitoring Devices Companies – Pipeline Products by Stage of Development
4.2 Cardiovascular Monitoring Devices – Pipeline Products by Stage of Development
5 Cardiovascular Monitoring Devices Companies and Product Overview
5.1 Acorai AB Company Overview
5.1.1 Acorai AB Pipeline Products & Ongoing Clinical Trials Overview
5.2 Admittance Technologies, Inc. Company Overview
5.2.1 Admittance Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Agatsa Software Pvt Ltd Company Overview
5.3.1 Agatsa Software Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.4 Amazec Photonics BV Company Overview
5.4.1 Amazec Photonics BV Pipeline Products & Ongoing Clinical Trials Overview
5.5 Angel Medical Systems Inc Company Overview
5.5.1 Angel Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 AusculSciences Inc Company Overview
5.6.1 AusculSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Aventusoft LLC Company Overview
5.7.1 Aventusoft LLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 Ben-Gurion University of the Negev Company Overview
5.8.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
5.9 Biomedical Acoustics Research Co Company Overview
5.9.1 Biomedical Acoustics Research Co Pipeline Products & Ongoing Clinical Trials Overview
5.10 Biorics NV Company Overview
5.10.1 Biorics NV Pipeline Products & Ongoing Clinical Trials Overview
5.11 Biotricity Inc Company Overview
5.11.1 Biotricity Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Biotronik SE & Co KG Company Overview
5.12.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
5.13 Boston Scientific Corp Company Overview
5.13.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 Bridgesource Medical Corp Company Overview
5.14.1 Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.15 Byteflies Company Overview
5.15.1 Byteflies Pipeline Products & Ongoing Clinical Trials Overview
5.16 Cambridge Heart, Inc. (Inactive) Company Overview
5.16.1 Cambridge Heart, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.17 Canary Medical Inc Company Overview
5.17.1 Canary Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Cardiac Network Inc (Inactive) Company Overview
5.18.1 Cardiac Network Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.19 CardiacConnect Corporation Company Overview
5.19.1 CardiacConnect Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.20 Cardiaccs AS Company Overview
5.20.1 Cardiaccs AS Pipeline Products & Ongoing Clinical Trials Overview
5.21 CardioComm Solutions Inc Company Overview
5.21.1 CardioComm Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 CardioLev Dynamics (HCS) Company Overview
5.22.1 CardioLev Dynamics (HCS) Pipeline Products & Ongoing Clinical Trials Overview
5.23 Cardiologic Innovations Limited (Inactive) Company Overview
5.23.1 Cardiologic Innovations Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.24 Cardiovasc.tech Inc Company Overview
5.24.1 Cardiovasc.tech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Cardiowatch Ltd. Company Overview
5.25.1 Cardiowatch Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.26 Casana Company Overview
5.26.1 Casana Pipeline Products & Ongoing Clinical Trials Overview
5.27 Cheetah Medical Inc Company Overview
5.27.1 Cheetah Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Coland Holdings Limited Company Overview
5.28.1 Coland Holdings Limited Pipeline Products & Ongoing Clinical Trials Overview
5.29 CorAlert Ltd Company Overview
5.29.1 CorAlert Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.30 CorTronix Biomedical Advancement Technologies Inc (Inactive) Company Overview
5.30.1 CorTronix Biomedical Advancement Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.31 Creavo Medical Technologies Ltd Company Overview
5.31.1 Creavo Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.32 Ecole Polytechnique Federale de Lausanne Company Overview
5.32.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
5.33 Embryyo Technologies Pvt Ltd Company Overview
5.33.1 Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 Endotronix Inc Company Overview
5.34.1 Endotronix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Eso-Technologies, Inc. Company Overview
5.35.1 Eso-Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.36 EXCMR, Ltd. Company Overview
5.36.1 EXCMR, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.37 Feelmore Labs Inc (Inactive) Company Overview
5.37.1 Feelmore Labs Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.38 Fraunhofer Institute for Applied Polymer Research Company Overview
5.38.1 Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview
5.39 Future Cardia Company Overview
5.39.1 Future Cardia Pipeline Products & Ongoing Clinical Trials Overview
5.40 Genetesis LLC Company Overview
5.40.1 Genetesis LLC Pipeline Products & Ongoing Clinical Trials Overview
5.41 Heart Test Laboratories Inc Company Overview
5.41.1 Heart Test Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.42 Heart Tronics, Inc. (Inactive) Company Overview
5.42.1 Heart Tronics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.43 HeartBeam Inc Company Overview
5.43.1 HeartBeam Inc Pipeline Products & Ongoing Clinical Trials Overview
5.44 HeartSounds, Inc. Company Overview
5.44.1 HeartSounds, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.45 Heyan Health Solutions Pvt Ltd Company Overview
5.45.1 Heyan Health Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.46 Huntleigh Healthcare Ltd Company Overview
5.46.1 Huntleigh Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.47 IMEC Company Overview
5.47.1 IMEC Pipeline Products & Ongoing Clinical Trials Overview
5.48 Indian Institute of Technology Kharagpur Company Overview
5.48.1 Indian Institute of Technology Kharagpur Pipeline Products & Ongoing Clinical Trials Overview
5.49 Infinite Biomedical Technologies LLC Company Overview
5.49.1 Infinite Biomedical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.50 Integrated Sensing Systems Inc Company Overview
5.50.1 Integrated Sensing Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.51 iNTELOMED Company Overview
5.51.1 iNTELOMED Pipeline Products & Ongoing Clinical Trials Overview
5.52 Intersection Medical, Inc. Company Overview
5.52.1 Intersection Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.53 Johns Hopkins University Company Overview
5.53.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.54 Keck School of Medicine of the University of Southern California Company Overview
5.54.1 Keck School of Medicine of the University of Southern California Pipeline Products & Ongoing Clinical Trials Overview
5.55 Knight Therapeutics Inc Company Overview
5.55.1 Knight Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.56 Korea Advanced Institute of Science and Technology Company Overview
5.56.1 Korea Advanced Institute of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
5.57 Lidco Group Ltd Company Overview
5.57.1 Lidco Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.58 Mayo Clinic Company Overview
5.58.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.59 Medtronic Plc Company Overview
5.59.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.60 Mergenet Medical, Inc. Company Overview
5.60.1 Mergenet Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.61 Mesuron Inc Company Overview
5.61.1 Mesuron Inc Pipeline Products & Ongoing Clinical Trials Overview
5.62 MicroPort Scientific Corp Company Overview
5.62.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.63 Millennium HealthCare Inc Company Overview
5.63.1 Millennium HealthCare Inc Pipeline Products & Ongoing Clinical Trials Overview
5.64 MindMics Company Overview
5.64.1 MindMics Pipeline Products & Ongoing Clinical Trials Overview
5.65 Minnesota Health Solutions Corporation Company Overview
5.65.1 Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.66 Monitra Healthcare Pvt Ltd Company Overview
5.66.1 Monitra Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.67 Nanyang Technological University Company Overview
5.67.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview
5.68 NeoMed Technologies, Inc. Company Overview
5.68.1 NeoMed Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.69 New World Technologies Inc Company Overview
5.69.1 New World Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.70 Nicrem S.r.l. Company Overview
5.70.1 Nicrem S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
5.71 Nihon Kohden Corp Company Overview
5.71.1 Nihon Kohden Corp Pipeline Products & Ongoing Clinical Trials Overview
5.72 Nimble Diagnostics Company Overview
5.72.1 Nimble Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.73 Noninvasive Medical Technologies Inc Company Overview
5.73.1 Noninvasive Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.74 Northwestern University Company Overview
5.74.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.75 Novosense AB Company Overview
5.75.1 Novosense AB Pipeline Products & Ongoing Clinical Trials Overview
5.76 Odyssey Health Inc Company Overview
5.76.1 Odyssey Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.77 Ohio State University Company Overview
5.77.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
5.78 Oxford Cardiomox Ltd Company Overview
5.78.1 Oxford Cardiomox Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.79 Peacs BV Company Overview
5.79.1 Peacs BV Pipeline Products & Ongoing Clinical Trials Overview
5.80 Precision Cardiovascular Ltd Company Overview
5.80.1 Precision Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.81 Quantum Innovations Company Overview
5.81.1 Quantum Innovations Pipeline Products & Ongoing Clinical Trials Overview
5.82 Rapid Rhythm Ltd Company Overview
5.82.1 Rapid Rhythm Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.83 Rindex Medical, Inc. Company Overview
5.83.1 Rindex Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.84 Rochester Institute of Technology Company Overview
5.84.1 Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.85 Scinovia Corporation Company Overview
5.85.1 Scinovia Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.86 Scivanta Medical Corp (Inactive) Company Overview
5.86.1 Scivanta Medical Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.87 Sensydia Corp Company Overview
5.87.1 Sensydia Corp Pipeline Products & Ongoing Clinical Trials Overview
5.88 Singapore General Hospital Company Overview
5.88.1 Singapore General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.89 Spectrocor Oy Company Overview
5.89.1 Spectrocor Oy Pipeline Products & Ongoing Clinical Trials Overview
5.90 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.90.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.91 St. Jude Medical LLC Company Overview
5.91.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.92 Stanford University Company Overview
5.92.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.93 Suzhou Kadi Merck Medical Devices Co Ltd Company Overview
5.93.1 Suzhou Kadi Merck Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.94 Thornhill Medical Company Overview
5.94.1 Thornhill Medical Pipeline Products & Ongoing Clinical Trials Overview
5.95 Three Rivers Cardiovascular Systems Inc Company Overview
5.95.1 Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.96 Tioga Ltd Company Overview
5.96.1 Tioga Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.97 Transoma Medical Inc (Inactive) Company Overview
5.97.1 Transoma Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.98 Transonic Systems Inc Company Overview
5.98.1 Transonic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.99 University of California Berkeley Company Overview
5.99.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
5.100 University of California San Francisco Company Overview
5.100.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.101 University of Colorado Company Overview
5.101.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.102 University of Houston Company Overview
5.102.1 University of Houston Pipeline Products & Ongoing Clinical Trials Overview
5.103 University of Illinois at Chicago Company Overview
5.103.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.104 University of Leeds Company Overview
5.104.1 University of Leeds Pipeline Products & Ongoing Clinical Trials Overview
5.105 University of Michigan Company Overview
5.105.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.106 University of Michigan Pediatric Device Consortium Company Overview
5.106.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview
5.107 University of Minnesota Company Overview
5.107.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.108 University of Oslo Company Overview
5.108.1 University of Oslo Pipeline Products & Ongoing Clinical Trials Overview
5.109 University of Pittsburgh Company Overview
5.109.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
5.110 University of Tampere Company Overview
5.110.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview
5.111 University of Utah Company Overview
5.111.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
5.112 University of Valencia Company Overview
5.112.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
5.113 University of Vermont Company Overview
5.113.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview
5.114 University of Virginia Company Overview
5.114.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview
5.115 University of Washington Company Overview
5.115.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
5.116 Vectorious Medical Technologies Ltd Company Overview
5.116.1 Vectorious Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.117 VectraCor Inc Company Overview
5.117.1 VectraCor Inc Pipeline Products & Ongoing Clinical Trials Overview
5.118 VeinAid, LLC Company Overview
5.118.1 VeinAid, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.119 VenoVision Company Overview
5.119.1 VenoVision Pipeline Products & Ongoing Clinical Trials Overview
5.120 VentriPoint Diagnostics Ltd Company Overview
5.120.1 VentriPoint Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.121 Vigilio S.A. Company Overview
5.121.1 Vigilio S.A. Pipeline Products & Ongoing Clinical Trials Overview
5.122 Vital Metrix Inc Company Overview
5.122.1 Vital Metrix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.123 Vixiar Medical Inc Company Overview
5.123.1 Vixiar Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.124 Washington State University Company Overview
5.124.1 Washington State University Pipeline Products & Ongoing Clinical Trials Overview
5.125 ZBeats Inc Company Overview
5.125.1 ZBeats Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Cardiovascular Monitoring Devices- Recent Developments
6.1 Oct 28, 2024: ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call
6.2 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
6.3 Oct 22, 2024: iRhythm secures 510(k) clearance for Zio device updates after FDA warning
6.4 Oct 21, 2024: Coloplast’s Invitation for Conference Call on 5 November 2024 at
11.00 CET
6.5 Oct 14, 2024: Acarix Secures Expansion Order from Existing CADScor System Customer
6.6 Oct 08, 2024: Multi-Location Customer Places Order of the Acarix CADScor System with Goal to Scale Usage
6.7 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
6.8 Oct 04, 2024: CONMED Corp Announces Preliminary Third Quarter Financial Information
6.9 Oct 03, 2024: ICU Medical Appoints New President
6.10 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
6.11 Sep 30, 2024: Mezoo Receives FDA 510(k) Clearance for HiCardi+H100
6.12 Sep 30, 2024: Cardiocomm Solutions Secures Health Canada Clearance for Artificial Intelligence ECG Interpretation for Multiple Cardiac Arrhythmias
6.13 Sep 26, 2024: Cardiex Announces Publication of Breakthrough Study Validating Noninvasive Fingertip Photoplethysmography (PPG) for Central Aortic Pressure Waveform Analysis
6.14 Sep 24, 2024: InfoBionic.Ai Announces Inclusion of MoMe ARC Solution in Connection Hub on Epic Showroom
6.15 Sep 22, 2024: Ivy Biomedical Systems Receives 510(K) Clearance For RT Carbon ECG Lead
6.16 Sep 19, 2024: SHL Telemedicine Announces 2024 Half-Year Results Call
6.17 Sep 18, 2024: Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents
6.18 Sep 12, 2024: iRhythm’s Zio ECG monitoring system secures Japanese regulatory approval
6.19 Sep 10, 2024: Remington Medical Receives Additional FDA 510(k) Clearance for VascuChek Clinical Device
6.20 Sep 09, 2024: iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio Monitor at HRX 2024 Meeting
6.21 Sep 09, 2024: Ventripoint to Launch Reference Site Programme to Deepen Collaborations with Hospital Partners
6.22 Sep 05, 2024: Netech Releases New State-of-the-Art EEG Simulator: MiniSim EEG 2000
6.23 Sep 02, 2024: Singapore General Hospital Names New CEO
6.24 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
6.25 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
6.26 Aug 26, 2024: Acarix Secures Order with National Concierge Healthcare Organization
6.27 Aug 21, 2024: Biotricity Reports Continued Margin Improvement and Reduced Losses in Its First Quarter Fiscal Year 2025
6.28 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
6.29 Aug 07, 2024: McKesson Announces Fiscal 2025 Q1 Results
6.30 Aug 06, 2024: Leading Cardiac Diagnostics Innovator Zywie Announces Industry Partnership With MedAxiom
6.31 Aug 06, 2024: Zywie Enters Into Partnership With MedAxiom
6.32 Aug 02, 2024: Nihon Kohden Announces Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2025
6.33 Aug 01, 2024: 3M Names Anurag Maheshwari as Executive Vice President and Chief Financial Officer
6.34 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance
6.35 Aug 01, 2024: iRhythm Technologies Chief Financial Officer to Step Down on August 31, 2024
6.36 Jul 29, 2024: ACIST Medical Systems Receives FDA 510(k) Clearance for ACIST Rapid Exchange (RXi) System
6.37 Jul 26, 2024: Innovation Value Institute Analysis Demonstrates Heartsciences’ Myovista Wavecg Potential to Improve Cardiovascular Pathway Efficiency
6.38 Jul 26, 2024: 3M Delivers Strong Second-Quarter Results; Company Updates Full-Year 2024 Earnings Guidance
6.39 Jul 25, 2024: HeartSciences Selected to Demonstrate MyoVista wavECG at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
6.40 Jul 24, 2024: Rhythmedix Receives Additional FDA 510(k) Clearance for RhythmStar System
6.41 Jul 24, 2024: ICU Medical Announces Time of Second Quarter 2024 Earnings Conference Call
6.42 Jul 22, 2024: Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud
6.43 Jul 17, 2024: AliveCor’s Kardia 12L ECG System Receives Category III CPT Codes
6.44 Jul 17, 2024: ICU Medical Plans to Close Oakdale Facility, Lay Off 83 Employees
6.45 Jul 10, 2024: AliveCor launches InstantQT in Europe for ECG evaluations
6.46 Jul 10, 2024: 3M Announces Departure of Chief Financial Officer
6.47 Jul 08, 2024: Vectorious Medical Technologies Reports Novel Findings From VECTOR HF Trials: Self-Management of Heart Failure Patients Using Left Atrial Pressure
6.48 Jul 08, 2024: CONMED to Announce Second Quarter 2024 Financial Results on July 31, 2024
6.49 Jul 04, 2024: Endotronix Obtains Pre-Market Approval (PMA) Clearance for Cordella PA Pressure Sensor
6.50 Jun 28, 2024: Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available
6.51 Jun 25, 2024: AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System
6.52 Jun 24, 2024: Endotronix Receives FDA Premarket Approval of the Cordella PA Sensor System for the Treatment of Heart Failure
6.53 Jun 24, 2024: Ventripoint to Present Its AI-Enhanced Cardiac Ultrasound Technology to B.C. And Canadian Health Care Leaders at the Data Effect
6.54 Jun 20, 2024: New, Simple Test Detects Rare Fatal Genetic Heart Condition
6.55 Jun 19, 2024: AliveCor Receives 510(K) Clearance For Corvair
6.56 Jun 19, 2024: AliveCor Receives 510(K) Clearance For Impala
6.57 Jun 19, 2024: Shenzhen Le Medical Technology Receives 510(K) Clearance For Electrocardiograph Model: ECG301
6.58 Jun 19, 2024: Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024
6.59 Jun 18, 2024: Circadia Technologies Receives 510(K) Clearance For Circadia C200 System
6.60 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
6.61 Jun 13, 2024: eReserchTechnology Receives 510(K) Clearance For CardioSphere
6.62 Jun 13, 2024: Medtronic Confirms Global Layoffs
6.63 Jun 11, 2024: Philips Aims to Transform Diagnostic Cardiology with Introduction of New Cardiac Workstation
6.64 Jun 05, 2024: AliveCor’s AI-backed ECG Offerings Featured in New Film Series on Innovative Technologies Presented by the Consumer Technology Association
6.65 Jun 05, 2024: ACSD Granted Significant Telemedicine Patent
6.66 May 27, 2024: Cardiomatics Partners With Biotronik In Germany To Expand Market Access Of Its Advanced Ai-powered ECG Analysis Solution
6.67 May 23, 2024: Physio-Control Receives FDA 510(k) Clearance for LIFEPAK ECG Cables
6.68 May 22, 2024: InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
6.69 May 20, 2024: HeartBeam’s AI device outperforms experts in detecting atrial flutter
6.70 May 20, 2024: HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
6.71 May 14, 2024: InfoBionic.Ai Announces Next-Generation Advancements in the MoMe ARC Suite of Products
6.72 May 13, 2024: HeartBeam’s AIMIGo Recognized as ‘Best New ECG Technology Solution’ in Awards Program
6.73 May 07, 2024: Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference
6.74 May 01, 2024: Duke University Health Center One of America’s Top Heart-care Institutions and Innovators – Purchases Ventripoint’s AI Heart-scan Technology
6.75 Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
6.76 Apr 29, 2024: Acarix Receives Order From the First Freestanding Emergency Room in the US
6.77 Apr 26, 2024: Biotricity’s Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers
6.78 Apr 24, 2024: HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
6.79 Apr 23, 2024: Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome
6.80 Apr 23, 2024: ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call
6.81 Apr 19, 2024: AMCG Receives 510(K) Clearance For MCG-S Heart Magnetometer Model: AM1000
6.82 Apr 18, 2024: Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics
6.83 Apr 16, 2024: Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital Network
6.84 Apr 15, 2024: Inmode Responds to Btl Petition for Inter Partes Review of Patent Inmode Is Asserting against Btl
6.85 Apr 12, 2024: Tri-City Cardiology’s Ambulatory Surgical Center (ASC) Leads the way in Revolutionizing Heart Failure Management
6.86 Apr 09, 2024: HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
6.87 Apr 08, 2024: New Health Economic Analysis Presented at ACC Highlights the Acarix Cadscor System’s Cost-Effectiveness
6.88 Apr 05, 2024: SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023
6.89 Mar 28, 2024: Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call
6.90 Mar 26, 2024: HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
6.91 Mar 21, 2024: Biotricity Partners with Health Aid Africa to Provide Complementary Heart Health Screenings at Allegiant Stadium Concert
6.92 Mar 19, 2024: Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
6.93 Mar 14, 2024: First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo System for Synthesizing a 12-Lead ECG
6.94 Mar 13, 2024: 3M Names New CEO Amid PFAS Battles, Health Spinoff
6.95 Mar 12, 2024: HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
6.96 Mar 12, 2024: 3M Announces New Leadership Appointments
6.97 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
6.98 Mar 08, 2024: HeartBeam secures new patents for cardiac monitoring technology
6.99 Mar 08, 2024: Wellysis and Artella Solutions Launch Innovative Remote Cardiac Monitoring Service in the US.
6.100 Mar 06, 2024: Heartsciences Announces Canada Patent Grant Covering Myovista Wavelet Technology
6.101 Mar 05, 2024: Endotronix Presents Positive PROACTIVE-HF Clinical Trial Results for its Cordella Pulmonary Artery Sensor
6.102 Mar 05, 2024: ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices Cardiopulmonary Management (CPM) System
6.103 Mar 04, 2024: Enhanced Design Breakthrough Makes Ventripoint’s VMS+ Even Simpler to Use
6.104 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
6.105 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
6.106 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
6.107 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
6.108 Feb 22, 2024: Wellysis Receives Additional 510(K) Clearance for S-Patch Ex Wearable ECG Patch
6.109 Feb 22, 2024: UltraLinQ Launches New Wearable Holter Device with UbiqVue ECG Analysis and Interpretation Software
6.110 Feb 20, 2024: Ventripoint Successfully Showcases A.I.-Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences
6.111 Feb 20, 2024: Philips Delivers Strong ESG Performance in 2023
6.112 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences
6.113 Feb 13, 2024: PCA 500– The World’s Most Efficient and Versatile 12-Lead ECG, Receives FDA Clearance for Use in Acute Care
6.114 Feb 08, 2024: Synovis Micro Companies Alliance Receives 510(K) Clearance For Gem Flow Now (GEM2770-FN)
6.115 Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
6.116 Feb 07, 2024: Delve Health and AliveCor Collaborate to Revolutionize Digital Healthcare Solutions in Cardiology
6.117 Feb 07, 2024: Ohio State Names New Senior Vice President of Talent, Culture and Human Resources
6.118 Feb 07, 2024: McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance
6.119 Feb 05, 2024: Acarix CADScor System Now Listed on U.S. VA Federal Supply Schedule
6.120 Feb 02, 2024: Acarix CADScor System Now Listed on US Federal Supply Schedule
6.121 Feb 01, 2024: Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine’s SmartHeart Technology, to Be Presented at ACC 24
6.122 Feb 01, 2024: New 4D Imaging May Detect Poor Pumping in Deadly Heart Disease
6.123 Jan 24, 2024: Wellysis Goes Global with ECG Monitor ‘S-Patch’, Enters US and Indian Markets
6.124 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024
6.125 Jan 16, 2024: Sensydia Completes Fifth Study for Heart-Sound AI
6.126 Jan 16, 2024: 3M Picks Former NuVasive CEO as President of Medical Solutions
6.127 Jan 16, 2024: Research Shows How a Tiny Device in the Ear Canal Can Monitor Heart Health
6.128 Jan 05, 2024: Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm’s Zio Long-Term Continuous Monitoring Service
6.129 Jan 05, 2024: Endotronix seeks FDA approval for Cordella PA sensor system
6.130 Jan 05, 2024: Boston Scientific Announces Conference Ca